Evidence map›Paper›PMID 32535653›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.

E J van Helden, S G Elias, S L Gerritse, S C van Es, E Boon, M C Huisman, N C T van Grieken, H Dekker, G A M S van Dongen, D J Vugts and 8 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

  • Erratum for
    [2020
5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

E J van HeldenMedical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
S G EliasJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
S L GerritseMedical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
S C van EsMedical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
E BoonMedical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
M C HuismanRadiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
N C T van GriekenPathology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
H DekkerMedical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
G A M S van DongenRadiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
D J VugtsRadiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
R BoellaardRadiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
C M L van HerpenMedical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
E G E de VriesMedical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
W J G OyenRadiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
A H BrouwersNuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
H M W VerheulMedical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
O S HoekstraRadiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
C W Menke-van der Houven van OordtMedical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands. c.menke@amsterdamumc.nl.
Cancer Center AmsterdamAmsterdam University Medical Centers · NLRadboud University Medical Center · NLUniversity Medical Center Groningen · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Missing Electronic Supplementary Materials.

Identifiers

PMID32535653
PMCPMC7645532
OpenAlexW3035408027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.